ALJAZEERA: European manufacturer of an emergency contraceptive drug identical to Plan-B, more commonly known as the morning-after pill, will soon issue warnings on packaging sold in Europe after research found that the drug loses its effectiveness in women who weigh more than 165 pounds, according to a Mother Jones report published Monday…
Sold under the name Norlevo, the emergency contraceptive contains a compound called levonorgestrel to prevent pregnancies. Clinical data from 2011 revealed that pills containing levonorgestrel are likely to fail in women with a higher body mass index, according to Mother Jones.
Specifically, the research showed that the drug is completely ineffective for women who weigh more than 176 pounds, and begins to lose effectiveness in women who weigh more than 165 pounds… (more)
